Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Owens & Minor ( (OMI) ) just unveiled an announcement.
On December 16, 2025, Owens & Minor’s board approved an amendment to its Executive Deferred Compensation and Retirement Plan that will freeze participation and all contributions for existing participants effective January 1, 2026, signaling a tightening of executive benefit structures that could modestly affect long-term compensation planning for senior leaders. Two days later, on December 18, 2025, the company announced it will change its corporate name to Accendra Health, Inc., with the parent-level name change expected to take effect around December 31, 2025 and its New York Stock Exchange ticker to shift from “OMI” to “ACH” when trading under the new identity begins on or about January 2, 2026, underscoring a strategic transformation toward becoming a pure-play leader in the home-based care market while continuing to operate under the established Apria and Byram brands without requiring any action from shareholders.
The most recent analyst rating on (OMI) stock is a Hold with a $2.50 price target. To see the full list of analyst forecasts on Owens & Minor stock, see the OMI Stock Forecast page.
Spark’s Take on OMI Stock
According to Spark, TipRanks’ AI Analyst, OMI is a Neutral.
Owens & Minor’s overall stock score is primarily impacted by its poor financial performance, with significant challenges in revenue, profitability, and cash flow. The technical analysis indicates a bearish trend, and the valuation is unattractive due to negative earnings and no dividend yield. The earnings call provided some positive strategic shifts, but these are overshadowed by ongoing operational issues and financial instability.
To see Spark’s full report on OMI stock, click here.
More about Owens & Minor
Owens & Minor, Inc., soon to be renamed Accendra Health, Inc., is a Fortune 500 global healthcare solutions company providing essential products and services that support care from the hospital to the home. Through affiliated brands including Apria, Byram Healthcare, and HALYARD, the company focuses on home-based care and broader healthcare supply offerings, serving patients, providers, and communities worldwide with a workforce of more than 20,000 employees.
Average Trading Volume: 2,194,447
Technical Sentiment Signal: Sell
Current Market Cap: $239.8M
See more insights into OMI stock on TipRanks’ Stock Analysis page.